The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK

Annals of the Rheumatic Diseases

Volumn 74, Issue 1, 2015, Pages 129-135

  Robson, Joanna C ^a   Kiran, Amit ^a   Maskell, Joe ^b   Hutchings, Andrew ^c   Arden, Nigel ^a   Dasgupta, Bhaskar ^d   Hamilton, William ^e   Emin, Akan ^f   Culliford, David ^b   Luqmani, Raashid A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d BASILDON HOSPITAL   (United Kingdom)

^e UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^f ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOCORTICOID;

ADULT; AGE; AGED; AORTA ANEURYSM; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; GIANT CELL ARTERITIS; GOLD STANDARD; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PARALLEL DESIGN; POPULATION RESEARCH; PREDICTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SMOKING; UNITED KINGDOM; AORTIC ANEURYSM; CARDIOVASCULAR DISEASES; MIDDLE AGED; STATISTICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; AORTIC ANEURYSM; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; GIANT CELL ARTERITIS; GREAT BRITAIN; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SMOKING; STATISTICS AS TOPIC;

EID: 84918557483     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204113     Document Type: Article

References (34)

1. Smeeth L, Cook C, Hall AJ Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis 2006; 65:1093-8.
2. Nuenninghoff DM, Hunder GG, Christianson T.J., et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003; 48:3522-31.
3. Gonzalez-Gay M.A., Garda-Porrua C, Pineiro A., et al. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore) 2004; 83:335-41.
4. Garcia-Martinez A., Hernandez-Rodriguez J, Arguis P., et al. Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum 2008; 59:422-30.
5. Ray JG, Mamdani MM, Geerts WH Giant cell arteritis and cardiovascular disease in older adults. Heart 2005; 91:324-8.
6. Evans JM, O'Fallon WM, Hunder GG Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995; 122:502-7.
7. Mackie SL, Hensor EM, Morgan A.W., et al. Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis. Ann Rheum Dis. Published Online First 22 Dec 2012.
8. Dasgupta ES, Borg FA, Hassan N, et al BSR and ESHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford) 2010; 49:1594-7.
9. Mukhtyar C, Guillevin L, Cid M.C., et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009; 68:318-23.
10. Vardulaki KA, Prevost TC, Walker N.M., et al. Incidence among men of asymptomatic abdominal aortic aneurysms: estimates from 500 screen detected cases. J Med Screen 1999; 6:50-4.
11. Svensjo S, Bjorck M, Gurtelschmid M., et al. Low prevalence of abdominal aortic aneurysm among 65-year-old Swedish men indicates a change in the epidemiology of the disease. Circulation 2011; 124:1118-23.
12. The UK Small Aneurysms Trial Participants. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 1998; 352:1649-55.
13. Basnyat PS, Biffin A, Moseley L., et al. Vascular surgical society of great britain and ireland: deaths from ruptured abdominal aortic aneurysm in wales. Br J Surg 1999; 86:693.
14. Cosford PA, Leng GC Screening for abdominal aortic aneurysm. Cochrane Database Syst Rev 2007; CD002945.
15. NHS Abdominal Aortic Aneurysm Screening Programme. http://aaa.screening.nhs.uk/
16. U.S. Preventive Services Task Force. Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med 2005; 142:198-202.
17. Sode BF, Nordestgaard BG, Gronbaek M, et al Tobacco smoking and aortic aneurysm: two population-based studies. Int J Cardiol 2012; 167:2271-7.
18. Lederle FA, Johnson GR, Wilson S.E., et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med 2000; 160:1425-30.
19. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997; 350:1097-9.
20. Dunne JA, Bailey MA, Griffin K.J., et al. Statins: the holy grail of Abdominal Aortic Aneurysm (AAA) growth attenuation? A systematic review of the literature. Curr Vasc Pharmacol 2012 [Epub ahead of print].
21. Royston P. Multiple imputation of missing values: update of ice. The Stata Journal 2005; 5:527-36.
22. Barnard J, Meng XL Applications of multiple imputation in medical studies: from AIDS to NHANES. Stat Methods Med Res 1999; 8:17-36.
23. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94:496-509.
24. Machado EB, Gabriel SE, Beard C.M., et al. A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? Int J Epidemiol 1989; 18:836-41.
25. Duhaut P, Pinede L, Demolombe-Rague S, et al. Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l'Arterite a Cellules Geantes. Arthritis Rheum 1998; 41:1960-5.
26. Larsson K, Mellstrom D, Nordborg E., et al. Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis. Ann Rheum Dis 2006; 65:529-32.
27. Lederle FA, Larson JC, Margolis K.L., et al. Abdominal aortic aneurysm events in the women's health initiative: cohort study. BMJ 2008; 337:a1724.
28. Rodin MB, Daviglus ML, Wong G.C., et al. Middle age cardiovascular risk factors and abdominal aortic aneurysm in older age. Hypertension 2003; 42:61-8.
29. Iribarren C, Darbinian JA, Go A.S., et al. Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: the Kaiser multiphasic health checkup cohort study. Ann Epidemiol 2007; 17:669-78.
30. Golledge J, Karan M, Moran C.S., et al. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur Heart J 2008; 29:665-72.
31. Phillip R, Luqmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 2008; 26:S94-104.
32. Crow RW, Katz BJ, Warner J.E., et al. Giant cell arteritis and mortality. J Gerontol A Biol Sci Med Sci 2009; 64:365-9.
33. Garcia-Martinez A., Arguis P, Preito-Gonzalez S, et al. Prospective evaluation of aortic structural damage (aneurysm/dilatation) using a predefined screening protocol in biopsy-proven giant-cell arteritis patients with extended follow-up. Arthritis Rheum 2011; 63:S593-4.
34. Mukhtyar C, Guillevin L, Cid M.C., et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009; 68:310-17.